Abbott Laboratories (ABT:NYSE) Strategic SWOT, PESTLE and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends
Report Summary
Abbott Laboratories (ABT:NYSE) Strategic SWOT, PESTLE and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report is a comprehensive and easily accessible overview of Abbott Laboratories's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Abbott Laboratories, including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Abbott Laboratories's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Abbott Laboratories's overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Abbott Laboratories's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Abbott Laboratories's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by Abbott Laboratories, enhancing awareness of the company's business trends, growth perspectives, and more.
Scope
• Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
• Comprehensive Understanding of the Abbott Laboratories's internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Abbott Laboratories:
• Abbott Laboratories Porter's Five Forces Analysis
• Abbott Laboratories VRIO Analysis
• Abbott Laboratories BCG Analysis
• Abbott Laboratories Segmentation, Targeting and Positioning (STP) Analysis
• Abbott Laboratories Ansoff Matrix Analysis
Tables
Charts
Abbott Laboratories - Key Company Facts
Abbott Laboratories - Company Description
Abbott Laboratories - Top Executives
Abbott Laboratories- Top Executives Biographies
Abbott Laboratories- Head Office & Locations
Head Office - Country
Key Subsidiaries
Abbott Laboratories - Products and Services
Products
Abbott Laboratories - Historic Events
Abbott Laboratories – Company’s Management Discussion
Abbott Laboratories – Company’s Mission and Vision
Mission
Abbott Laboratories - Corporate Strategy
Abbott Laboratories - Business Description
Established Pharmaceuticals
Medical Devices
Nutrition
Diagnostics
Abbott Laboratories - ESG Spotlight
Environment
Social
Corporate Governance
Abbott Laboratories - SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Abbott Laboratories – PESTLE Analysis
Overview
Political Factors
Economic Factors
Social Factors
Technological Factors
Legal Factors
Environmental Factors
Abbott Laboratories - Financial Deep Dive
Share Price Trend - Dec-2022 to Nov-2023 (Average Share Closing Price)
Profit and Loss Statement
Summary of Profit and Loss Statement
Balance Sheet
Summary of Balance Sheet
Cash Flow Statement
Summary of Cash Flow Statement
Key Financial Ratio Analysis
Abbott Laboratories - Ratio Charts
Activity Ratio Charts
Growth Ratios Charts
Leverage Ratio Charts
Liquidity Ratio Charts
Profitability Ratio Charts
Competing Players
Snapshot of Competing Players
Boston Scientific Corporation
Key Company Facts
Company Description
Snapshot of Competing Players
Johnson & Johnson
Key Company Facts
Company Description
Snapshot of Competing Players
Sanofi
Key Company Facts
Company Description
Snapshot of Competing Players
Stryker Corporation
Key Company Facts
Company Description
Abbott Laboratories - Key Deals
23-Nov-2023 - Abbott to upgrade 75 primary health centres across india, providing quality, accessible care to 2.5 million people
24-Jun-2023 - The american diabetes association and abbott collaborate on first-of-its-kind therapeutic nutrition program for people with diabetes
31-May-2023 - Abbott, real madrid and the real madrid foundation band together to 'beat malnutrition' globally through new campaign
27-Apr-2023 - Abbott completes acquisition of cardiovascular systems, inc.
20-Apr-2023 - Abbott and new global consortium partnership address viral outbreaks caused by climate change
13-Dec-2022 - Abbott and the brain injury association of america launch concussion awareness now coalition; team up with rebel wilson to raise awareness on seriousness of concussions
12-Oct-2022 - Abbott and the home edit redesign the medicine cabinet to help people prepare for the upcoming virus season
04-Aug-2022 - Abbott and weightwatchers partner to support people living with diabetes in attaining their health goals
22-Jun-2022 - Easterseals and the abbott fund join together to advance education and health equity
27-Apr-2022 - Abbott, camdiab and ypsomed unveil new automated insulin delivery partnership for people with diabetes
Abbott Laboratories - In the News
05-Jul-2023 - Abbott receives fda approval for world's first dual chamber leadless pacemaker
03-Jul-2023 - Abbott receives fda clearance for first commercially available lab-based blood test to help evaluate concussion
22-Jun-2023 - Abbott's freestyle libre® 2 receives national reimbursement in france for all people with diabetes who use insulin¹
03-Jun-2023 - U.S. Fda clears abbott's freestyle libre® 2 and freestyle libre® 3 sensors for integration with automated insulin delivery systems
19-May-2023 - Abbott receives fda approval for tactiflex™ ablation catheter for treatment of abnormal heart rhythm
18-May-2023 - Abbott receives fda clearance for assert-iq™ insertable cardiac monitor to help doctors monitor people's heart rhythms long-term
16-May-2023 - Abbott receives fda approval for its spinal cord stimulation systems to treat chronic back pain in people who have limited surgical options
30-Mar-2023 - Abbott receives fda approval for epic™ max tissue valve to treat aortic valve disease
02-Feb-2023 - Abbott announces u.S. And european approvals for new technologies to support effective treatment for abnormal heart rhythms
19-Dec-2022 - Abbott launches the world's smallest implantable, rechargeable spinal cord stimulation system for chronic pain
Appendix
Definitions
SWOT Analysis
PESTLE Analysis
Value Chain Analysis
ESG Spotlight
Financial Deep Dive
Financial Ratios -
Activity Ratios
Growth Ratios
Leverage Ratios
Liquidity Ratios
Market Ratios
Profitability Ratios
Research Methodology
Disclaimer
Contact Us
Table 1: Abbott Laboratories - Company Facts
Table 2: Abbott Laboratories - Top Executives
Table 3: Abbott Laboratories - Top Executives Biographies
Table 4: Abbott Laboratories - Subsidiaries
Table 5: Abbott Laboratories - Products
Table 6: Abbott Laboratories - Historic Events
Table 7: Abbott Laboratories - Share Price Trend - Dec-2022 to Nov-2023
Table 8: Abbott Laboratories - Ratio Analysis - 2019-2022
Table 9: Abbott Laboratories - Competing PlayersFigure 1: Abbott Laboratories- SWOT Analysis
Figure 2: Abbott Laboratories - PESTLE Analysis
Figure 3: Abbott Laboratories - Average Share Price Trend - Dec-2022 to Nov-2023
Figure 4: Abbott Laboratories - Profit and Loss Statement - 2019-2022
Figure 5: Abbott Laboratories - Balance Sheet - 2019-2022
Figure 6: Abbott Laboratories - Cash Flow Statement 2019-2022
Figure 7: Abbott Laboratories - Activity Ratio Charts
Figure 8: Abbott Laboratories - Growth Ratio Charts
Figure 9: Abbott Laboratories - Leverage Ratio Charts
Figure 10: Abbott Laboratories - Liquidity Ratio Charts
Figure 11: Abbott Laboratories - Profitability Ratio Charts
Figure 12: Competing Players - Boston Scientific Corporation- Key Financials
Figure 13: Competing Players - Johnson & Johnson- Key Financials
Figure 14: Competing Players - Sanofi- Key Financials
Figure 15: Competing Players - Stryker Corporation- Key Financials
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|